Novo Integrated Sciences, Inc. (Novo) announced the scheduling of its Virtual Annual Meeting for November 22, 2024. The meeting will address the election of five directors, approval of issuing common stock exceeding 19.99% pursuant to Nasdaq rules, a reverse stock split, and the ratification of Fruci & Associates II, PLLC as the independent registered public accounting firm for the fiscal year ending August 31, 2025. Shareholders of record as of September 27, 2024, are entitled to vote. The company emphasized the importance of shareholder votes, urging even those attending virtually to vote in advance. The meeting will also cover additional business as may arise. The Board of Directors has recommended voting in favor of all proposals, including the reverse stock split to comply with Nasdaq's minimum bid price requirement. The reverse stock split is proposed at a ratio between 1-for-10 and 1-for-30, to be determined by the Board. The company's stock is traded under the ticker NVOS.US.

Novo Integrated Sciences, Inc. (Novo) announced the scheduling of its Virtual Annual Meeting for November 22, 2024. The meeting will address the election of five directors, approval of issuing common stock exceeding 19.99% pursuant to Nasdaq rules, a reverse stock split, and the ratification of Fruci & Associates II, PLLC as the independent registered public accounting firm for the fiscal year ending August 31, 2025. Shareholders of record as of September 27, 2024, are entitled to vote. The company emphasized the importance of shareholder votes, urging even those attending virtually to vote in advance. The meeting will also cover additional business as may arise. The Board of Directors has recommended voting in favor of all proposals, including the reverse stock split to comply with Nasdaq's minimum bid price requirement. The reverse stock split is proposed at a ratio between 1-for-10 and 1-for-30, to be determined by the Board. The company's stock is traded under the ticker NVOS.US.